Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Boston Pharmaceuticals begins phase IIa study of BOS-589 in IBS-D

June 20, 2019

CRV-431 decreases fibrosis and key biomarkers of liver disease in experimental model

June 18, 2019

New PPAR agonists identified at Sichuan Kelun-Biotech Biopharmaceutical

June 18, 2019

Topline 12-week data reported from an ongoing phase IIb study of seladelpar in NASH

June 12, 2019

Hepagene Therapeutics identifies MAP3K5 inhibitors

June 11, 2019

Hepagene Therapeutics patents MEK kinase 5 inhibitors

June 6, 2019

Rifamycin SV-MMX evaluated in phase II study for acute uncomplicated diverticulitis

June 6, 2019

Phase II trial of MD-7246 for IBS-D abdominal pain begins dosing

June 4, 2019

Jeil Pharmaceutical divulges new H+/K+-ATPase inhibitors

June 4, 2019

Metacrine reports phase Ib interim data on FXR agonist MET-409 in NASH

May 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...